InnAVasc Medical said it raised $2.15 million in a new round of equity financing, according to an SEC filing posted today . InnAVasc is developing devices designed for vascular access during hemodialysis. The company’s 1st device is an arteriovenous graft modification which includes 2 multilayer cannulation chambers and low-bleed tech, designed to be resistant to […]
InnAVasc
HeartWare taps ex-Medtronic exec Oesterle for board | Personnel Moves
HeartWare International (NSDQ:HTWR) is looking to get in on Dr. Stephen Oesterle, an Ex-Medtronic (NYSE:MDT) exec who moved to the venture capital firm New Enterprise Associates last Sept., saying this week that it expanded its board to accommodate Oesterle. Oesterle will officially come aboard on Jan. 18, and his appointment included an expansion to HeartWare’s board […]
